July 14, 2025

TG Therapeutics, Inc. (TGTX): Investor Outlook with an 11.10% Upside Potential in Biotechnology

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, continues to capture investor interest with its promising pipeline and strategic focus on B-cell..

The Cooper Companies, Inc. (COO) Stock Analysis: Exploring a Potential 24% Upside

For investors seeking exposure to the healthcare sector, The Cooper Companies, Inc. (NYSE: COO) presents an intriguing opportunity. With a market cap of $14.92 billion, this..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Revenue Growth Soars Amid Promising Drug Pipeline

Cytokinetics, Incorporated (NASDAQ: CYTK), a notable player in the biotechnology sector, has captured investor attention with its robust 89.10% revenue growth and a promising pipeline of..

Glaukos Corporation (GKOS) Stock Analysis: Unveiling a 17.97% Potential Upside in the Medical Device Sector

Glaukos Corporation (NYSE: GKOS) is carving out a notable position within the healthcare sector, specifically in the medical devices industry. With a market capitalization of approximately..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Navigating a 7.34% Potential Upside in the Digital Healthcare Arena

iRhythm Technologies, Inc. (NASDAQ: IRTC) is making waves in the digital healthcare sector, capturing investor interest with its innovative solutions in ambulatory cardiac monitoring. Headquartered in..

Blueprint Medicines Corporation (BPMC) Stock Analysis: A Biotech with Potential Amidst Challenging Metrics

Blueprint Medicines Corporation (NASDAQ: BPMC), a prominent player in the biotechnology sector, is capturing investor attention with its robust pipeline of precision therapies targeting genomically defined..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 10.73% Potential Upside

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, specializing in diagnostics and research, captures investor attention with its notable growth potential and..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 28.64% Potential Upside with Strong Buy Ratings

United Therapeutics Corporation (NASDAQ: UTHR) stands out in the healthcare sector as a significant player in the specialty and generic drug manufacturing industry. With a robust..

Illumina, Inc. (ILMN) Stock Analysis: Evaluating Growth Potential Amidst Market Volatility

Illumina, Inc. (NASDAQ: ILMN), a prominent player in the healthcare sector specializing in diagnostics and research, is at a pivotal point as it navigates market fluctuations..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating a 65% ROE Amidst Market Volatility

Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the healthcare sector specializing in diagnostics and research, has captured investor attention with its impressive financial metrics,..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring a 113.78% Potential Upside in the Biotechnology Arena

Avidity Biosciences, Inc. (NASDAQ: RNA) is making compelling waves in the biotechnology sector with its innovative approach to RNA therapeutics. The company, headquartered in San Diego,..

Insmed Incorporated (INSM) Stock Analysis: A Look at the 12.10% Potential Upside in Biotech

For investors with a keen eye on the healthcare sector, Insmed Incorporated (NASDAQ: INSM) presents an intriguing opportunity within the biotechnology industry. With its focus on..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A 57.8% Upside Potential in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands as a compelling player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market..

Telix Pharmaceuticals (TLX) Stock Analysis: Exploring a 43.90% Potential Upside in the Biotech Space

Telix Pharmaceuticals Limited (ASX: TLX), a prominent player in the healthcare sector specializing in biotechnology, has been making waves with its innovative approach to radiopharmaceuticals. Headquartered..

Viatris Inc. (VTRS) Stock Analysis: Evaluating a 24.86% Potential Upside Amidst Financial Headwinds

For investors eyeing the healthcare sector, Viatris Inc. (NASDAQ: VTRS) presents a compelling opportunity worth closer examination. With a market capitalization of $10.7 billion, Viatris operates..

Insulet Corporation (PODD): Investor Outlook with 16% Potential Upside and Strong Buy Ratings

For investors with a focus on the healthcare sector, Insulet Corporation (NASDAQ: PODD) presents an intriguing opportunity. With a market cap of $20.36 billion, Insulet is..

Prestige Consumer Healthcare (PBH) Stock Analysis: Potential 15.69% Upside Amidst Robust Revenue Growth

Prestige Consumer Healthcare Inc. (NYSE: PBH) is making waves in the healthcare sector, attracting investor attention with a notable potential upside of 15.69% according to analyst..

Exelixis, Inc. (EXEL) Stock Analysis: Navigating Biotech Growth with Exciting Revenue Prospects

Exelixis, Inc. (NASDAQ: EXEL) presents a compelling case for investors looking for growth in the biotechnology sector. With a market capitalization of $12.23 billion, this oncology-focused..

Royalty Pharma plc (RPRX) Stock Analysis: Growth Potential with a 15.86% Upside

Royalty Pharma plc (NASDAQ: RPRX) is an intriguing prospect in the biotechnology sector, combining a unique business model with solid growth potential. As a leading acquirer..

Walgreens Boots Alliance (WBA) Investor Outlook: Navigating Challenges with a Robust Dividend Yield and Growth Potential

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a cornerstone in the pharmaceutical retail industry, offers a unique investment prospect for those navigating the healthcare sector. As a..

Search

Funds

July 14, 2025

Search

Funds

July 14, 2025

FTSE 100

Funds